| 臺大學術典藏 |
2021-08-03T03:53:15Z |
The long-term results of ureteral reimplantation by different antireflux techniques: Analysis of the trifecta, functional, anatomic, and surgical outcomes
|
CHI-SHIN TSENG; Wong, S-M.; Kuo, M-C.; Chow, P-M.; Huang, C-Y.; Pu, Y-S.; Chang, H-C. |
| 臺大學術典藏 |
2021-08-03T03:45:50Z |
Trifecta outcome of ureteral reconstruction in iatrogenic injury and non-iatrogenic ureteral lesions: a 10-year experience at a tertiary referral center
|
CHI-SHIN TSENG; Tai T.-E.; Hong C.-H.; Chen C.-H.; Chiang I.-N.; Lu Y.-C.; Hung S.-C.; Huang K.-H.; Huang C.-Y.; Chang H.-C.; Pu Y.-S.; Chow P.-M. |
| 臺大學術典藏 |
2021-08-03T03:45:48Z |
Outcomes and prediction models for exclusive prostate bed salvage radiotherapy among patients with biochemical recurrence after radical prostatectomy
|
CHI-SHIN TSENG; Wang Y.-J.; Chen C.-H.; Wang S.-M.; Huang K.-H.; Chow P.-M.; Pu Y.-S.; Huang C.-Y.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-07-01T03:47:18Z |
The covalent CDK7 inhibitor THZ1 enhances temsirolimus-induced cytotoxicity via autophagy suppression in human renal cell carcinoma
|
Chow P.-M.; SHING-HWA LIU; Chang Y.-W.; Kuo K.-L.; Lin W.-C.; Huang K.-H. |
| 臺大學術典藏 |
2021-05-25T07:42:09Z |
The application of p2PSA% and prostate health index in prostate cancer detection: A prospective cohort in a Tertiary Medical Center
|
Cheng Y.-T.; Chiang C.-H.; Pu Y.-S.; Liu S.P.; Lu Y.-C.; YI-KAI CHANG; Chang H.-C.; Huang K.-H.; Lee Y.-J.; Chow P.-M.; Hung S.-C.; Huang C.-Y. |
| 臺大學術典藏 |
2021-05-25T07:42:08Z |
Preoperative %p2PSA and Prostate Health Index Predict Pathological Outcomes in Patients with Prostate Cancer Undergoing Radical Prostatectomy
|
Cheng Y.-T.; Huang C.-Y.; Chen C.-H.; Chiu S.-T.; Hong J.-H.; Pu Y.-S.; Liu S.-P.; Lu Y.-C.; YI-KAI CHANG; Chang H.-C.; Huang K.-H.; Lee Y.-J.; Chow P.-M.; Chiang I.-N.; Hung S.-C.; Chiang C.-H. |
| 臺大學術典藏 |
2021-05-25T07:42:07Z |
Association between low prostate-specific antigen levels and greater disease progression in high-grade locally-advanced prostate cancer
|
Lu Y.-C.; Huang C.-Y.; Lu Y.-C.; Huang K.-H.; Chow P.-M.; YI-KAI CHANG; Hung F.-C.; Chen C.-H.; Jaw F.-S.; Hong J.-H. |
| 臺大學術典藏 |
2021-03-18T02:02:24Z |
Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma
|
Lin W.-C.;Hsu F.-S.;Kuo K.-L.;Liu S.-H.;Chia-Tung Shun;Shi C.-S.;Chang H.-C.;Tsai Y.-C.;Lin M.-C.;Wu J.-T.;Kuo Y.;Chow P.-M.;Liao S.-M.;Yang S.-P.;Hong J.-Y.;Huang K.-H.; Lin W.-C.; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; CHIA-TUNG SHUN; Shi C.-S.; Chang H.-C.; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; Huang K.-H. |
| 臺大學術典藏 |
2021-03-18T02:02:23Z |
Correction to: Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma (Journal of Molecular Medicine, (2018), 96, 12, (1307-1318), 10.1007/s00109-018-1697-7)
|
Lin W.-C.;Hsu F.-S.;Kuo K.-L.;Liu S.-H.;Chia-Tung Shun;Shi C.-S.;Chang H.-C.;Tsai Y.-C.;Lin M.-C.;Wu J.-T.;Kuo Y.;Chow P.-M.;Liao S.-M.;Yang S.-P.;Hong J.-Y.;Huang K.-H.; Lin W.-C.; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; CHIA-TUNG SHUN; Shi C.-S.; Chang H.-C.; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; Huang K.-H. |
| 臺大學術典藏 |
2021-03-04T02:35:55Z |
Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma
|
Lin W.-C.;Hsu F.-S.;Kuo K.-L.;Liu S.-H.;Shun C.-T.;Shi C.-S.;Chang H.-C.;Yu-Chieh Tsai;Lin M.-C.;Wu J.-T.;Kuo Y.;Chow P.-M.;Liao S.-M.;Yang S.-P.;Hong J.-Y.;Huang K.-H.; Lin W.-C.; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; Shun C.-T.; Shi C.-S.; Chang H.-C.; YU-CHIEH TSAI; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; Huang K.-H. |
| 臺大學術典藏 |
2021-03-04T02:35:54Z |
Correction to: Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma (Journal of Molecular Medicine, (2018), 96, 12, (1307-1318), 10.1007/s00109-018-1697-7)
|
Lin W.-C.;Hsu F.-S.;Kuo K.-L.;Liu S.-H.;Shun C.-T.;Shi C.-S.;Chang H.-C.;Yu-Chieh Tsai;Lin M.-C.;Wu J.-T.;Kuo Y.;Chow P.-M.;Liao S.-M.;Yang S.-P.;Hong J.-Y.;Huang K.-H.; Lin W.-C.; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; Shun C.-T.; Shi C.-S.; Chang H.-C.; YU-CHIEH TSAI; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; Huang K.-H. |
| 臺大學術典藏 |
2021-02-04T02:30:25Z |
Association between low prostate-specific antigen levels and greater disease progression in high-grade locally-advanced prostate cancer
|
Lu, Y.-C.;Huang, C.-Y.;Lu, Y.-C.;Huang, K.-H.;Chow, P.-M.;Chang, Y.-K.;Hung, F.-C.;Chen, C.-H.;Jaw, F.-S.;Hong, J.-H.Fu-Shan Jaw; Lu, Y.-C.; Huang, C.-Y.; Lu, Y.-C.; Huang, K.-H.; Chow, P.-M.; Chang, Y.-K.; Hung, F.-C.; Chen, C.-H.; Jaw, F.-S.; Hong, J.-H.; FU-SHAN JAW |
| 臺大學術典藏 |
2021-02-04T02:30:24Z |
Acrolein contributes to urothelial carcinomas in patients with chronic kidney disease
|
Hong, J.-H.;Lee, P.A.H.;Lu, Y.-C.;Huang, C.-Y.;Chen, C.-H.;Chiang, C.-H.;Chow, P.-M.;Jaw, F.-S.;Wang, C.-C.;Huang, C.-Y.;Wang, T.-W.;Liu, J.-H.;Wang, H.-T.Fu-Shan Jaw; Hong, J.-H.; Lee, P.A.H.; Lu, Y.-C.; Huang, C.-Y.; Chen, C.-H.; Chiang, C.-H.; Chow, P.-M.; Jaw, F.-S.; Wang, C.-C.; Huang, C.-Y.; Wang, T.-W.; Liu, J.-H.; Wang, H.-T.; FU-SHAN JAW |
| 臺大學術典藏 |
2021-02-02T00:46:34Z |
Pretreatment prostate specific antigen (PSA) and 2-year PSA dynamics: Early predictors of prostate cancer prognosis with external radiation therapy
|
Chow P.-M.; Chiang I.-N.; Cheng J.C.H.; Chiang B.-J.; YEONG-SHIAU PU; Huang C.-Y. |
| 臺大學術典藏 |
2021-02-02T00:46:28Z |
Metallic ureteral stents in malignant ureteral obstruction: Short-term results and radiological features predicting stent failure in patients with non-urological malignancies
|
Chow P.-M.;Hsu J.-S.;Wang S.-M.;Yu H.-J.;Yeong-Shiau Pu;Liu K.-L.; Chow P.-M.; Hsu J.-S.; Wang S.-M.; Yu H.-J.; YEONG-SHIAU PU; Liu K.-L. |
| 臺大學術典藏 |
2021-02-02T00:46:23Z |
Metallic ureteral stents in malignant ureteral obstruction: Clinical factors predicting stent failure
|
Chow P.-M.;Hsu J.-S.;Huang C.-Y.;Wang S.-M.;Lee Y.-J.;Huang K.-H.;Yu H.-J.;Yeong-Shiau Pu;Liang P.-C.; Chow P.-M.; Hsu J.-S.; Huang C.-Y.; Wang S.-M.; Lee Y.-J.; Huang K.-H.; Yu H.-J.; YEONG-SHIAU PU; Liang P.-C. |
| 臺大學術典藏 |
2021-02-02T00:46:18Z |
Malignant ureteral obstruction: Functional duration of metallic versus polymeric ureteral stents
|
Chow P.-M.;Chiang I.-N.;Chen C.-Y.;Huang K.-H.;Hsu J.-S.;Wang S.-M.;Lee Y.-J.;Yu H.-J.;Yeong-Shiau Pu;Huang C.-Y.; Chow P.-M.; Chiang I.-N.; Chen C.-Y.; Huang K.-H.; Hsu J.-S.; Wang S.-M.; Lee Y.-J.; Yu H.-J.; YEONG-SHIAU PU; Huang C.-Y. |
| 臺大學術典藏 |
2021-02-02T00:46:11Z |
Long-term outcomes of nephrectomy and inferior vena cava thrombectomy in patients with advanced renal cell carcinoma: A single-center experience
|
Lien C.-C.;Liu K.-L.;Chow P.-M.;Lin W.-C.;Tai H.-C.;Huang C.-Y.;Wang S.-M.;Huang K.-H.;Yeong-Shiau Pu; Lien C.-C.; Liu K.-L.; Chow P.-M.; Lin W.-C.; Tai H.-C.; Huang C.-Y.; Wang S.-M.; Huang K.-H.; YEONG-SHIAU PU |
| 臺大學術典藏 |
2021-02-02T00:46:00Z |
The application of p2PSA% and prostate health index in prostate cancer detection: A prospective cohort in a Tertiary Medical Center
|
Cheng Y.-T.;Chiang C.-H.;Yeong-Shiau Pu;Liu S.P.;Lu Y.-C.;Chang Y.-K.;Chang H.-C.;Huang K.-H.;Lee Y.-J.;Chow P.-M.;Hung S.-C.;Huang C.-Y.; Cheng Y.-T.; Chiang C.-H.; YEONG-SHIAU PU; Liu S.P.; Lu Y.-C.; Chang Y.-K.; Chang H.-C.; Huang K.-H.; Lee Y.-J.; Chow P.-M.; Hung S.-C.; Huang C.-Y. |
| 臺大學術典藏 |
2021-02-02T00:45:59Z |
Trifecta outcome of ureteral reconstruction in iatrogenic injury and non-iatrogenic ureteral lesions: a 10-year experience at a tertiary referral center
|
Tseng C.-S.;Tai T.-E.;Hong C.-H.;Chen C.-H.;Chiang I.-N.;Lu Y.-C.;Hung S.-C.;Huang K.-H.;Huang C.-Y.;Chang H.-C.;Yeong-Shiau Pu;Chow P.-M.; Tseng C.-S.; Tai T.-E.; Hong C.-H.; Chen C.-H.; Chiang I.-N.; Lu Y.-C.; Hung S.-C.; Huang K.-H.; Huang C.-Y.; Chang H.-C.; YEONG-SHIAU PU; Chow P.-M. |
| 臺大學術典藏 |
2021-02-02T00:45:58Z |
Effect of diabetes mellitus and glycemic control on the prognosis of non-muscle invasive bladder cancer: a retrospective study
|
Huang W.-L.;Huang K.-H.;Huang C.-Y.;Yeong-Shiau Pu;Chang H.-C.;Chow P.-M.; Huang W.-L.; Huang K.-H.; Huang C.-Y.; YEONG-SHIAU PU; Chang H.-C.; Chow P.-M. |
| 臺大學術典藏 |
2021-02-02T00:45:57Z |
Preoperative %p2PSA and Prostate Health Index Predict Pathological Outcomes in Patients with Prostate Cancer Undergoing Radical Prostatectomy
|
Cheng Y.-T.;Huang C.-Y.;Chen C.-H.;Chiu S.-T.;Hong J.-H.;Yeong-Shiau Pu;Liu S.-P.;Lu Y.-C.;Chang Y.-K.;Chang H.-C.;Huang K.-H.;Lee Y.-J.;Chow P.-M.;Chiang I.-N.;Hung S.-C.;Chiang C.-H.; Cheng Y.-T.; Huang C.-Y.; Chen C.-H.; Chiu S.-T.; Hong J.-H.; YEONG-SHIAU PU; Liu S.-P.; Lu Y.-C.; Chang Y.-K.; Chang H.-C.; Huang K.-H.; Lee Y.-J.; Chow P.-M.; Chiang I.-N.; Hung S.-C.; Chiang C.-H. |
| 臺大學術典藏 |
2021-02-02T00:43:04Z |
Metallic ureteral stents in malignant ureteral obstruction: Short-term results and radiological features predicting stent failure in patients with non-urological malignancies
|
Chow P.-M.;Hsu J.-S.;Wang S.-M.;Hong-Jeng Yu;Pu Y.-S.;Liu K.-L.; Chow P.-M.; Hsu J.-S.; Wang S.-M.; HONG-JENG YU; Pu Y.-S.; Liu K.-L. |
| 臺大學術典藏 |
2021-02-02T00:43:03Z |
Metallic ureteral stents in malignant ureteral obstruction: Clinical factors predicting stent failure
|
Chow P.-M.;Hsu J.-S.;Huang C.-Y.;Wang S.-M.;Lee Y.-J.;Huang K.-H.;Hong-Jeng Yu;Pu Y.-S.;Liang P.-C.; Chow P.-M.; Hsu J.-S.; Huang C.-Y.; Wang S.-M.; Lee Y.-J.; Huang K.-H.; HONG-JENG YU; Pu Y.-S.; Liang P.-C. |
| 臺大學術典藏 |
2021-02-02T00:43:01Z |
Malignant ureteral obstruction: Functional duration of metallic versus polymeric ureteral stents
|
Chow P.-M.;Chiang I.-N.;Chen C.-Y.;Huang K.-H.;Hsu J.-S.;Wang S.-M.;Lee Y.-J.;Hong-Jeng Yu;Pu Y.-S.;Huang C.-Y.; Chow P.-M.; Chiang I.-N.; Chen C.-Y.; Huang K.-H.; Hsu J.-S.; Wang S.-M.; Lee Y.-J.; HONG-JENG YU; Pu Y.-S.; Huang C.-Y. |
